investment in Canada
May 24 (Reuters) - AbCellera Biologics Inc ABCL.O said on Wednesday it will make a C$701 million ($524.23 million) co-investment with the governments of Canada and British Columbia to strengthen capabilities and infrastructure for drug development, manufacturing and clinical research in the country. ($1 = 1.3372 Canadian dollars) (Reporting by Sriparna Roy in Bengaluru; Editing by Devika Syamnath) ((Sriparna.Roy@thomsonreuters.com;))
Recent news on AbCellera Biologics
See all newsAbCellera Biologics Inc. reports results for the quarter ended September 30 - Earnings Summary
Canada's AbCellera Q3 revenue beats analyst estimates
Factbox: Pharma sector doubles down on AI to slash costs, timelines
U.S. STOCKS ON THE MOVE-Tapestry, Cisco, Sandisk
U.S. STOCKS ON THE MOVE-EnerSys, Netflix, Salesforce